INS and Insulin resistance: As insulin inhibits lipolysis and promotes lipogenesis and fat storage, the hyperinsulinemic conditions induced by insulin resistance and/or glucose-lowering medications with insulin or hypoglycemic agents that enhance endogenous insulin secretion are proposed as a potential cause of weight loss resistance in diabetic patients undergoing MBS [24,25,27].